Small-molecules that inhibit interactions between specific pairs of proteins have long repre-sented a promising avenue for therapeutic intervention in a variety of settings. Structural studies have shown that in many cases, the inhibitor-bound protein adopts a conformation that is distinct from its unbound and its protein-bound conformations. This plasticity of the protein surface presents a major challenge in predicting which members of a protein family will be inhibited by a given ligand. Here, we use biased simulations of Bcl-2-family proteins to generate ensembles of low-energy conformations that contain surface pockets suitable for small molecule binding. We find that the resulting conformational ensembles include sur-face pockets that...
<p>Distributions of RMSD over interface atoms (iRMSD) to the closest inhibitor-bound crystal structu...
Small-molecule drug design aims to identify inhibitors that can specifically bind to a functionally ...
Small-molecule drug design aims to identify inhibitors that can specifically bind to a functionally ...
<div><p>Small-molecules that inhibit interactions between specific pairs of proteins have long repre...
Small-molecules that inhibit interactions between specific pairs of proteins have long represented a...
Small-molecules that inhibit interactions between specific pairs of proteins have long represented a...
Despite intense interest and considerable effort via high-throughput screening, there are few exampl...
Despite intense interest and considerable effort via high-throughput screening, there are few exampl...
Despite intense interest and considerable effort via high-throughput screening, there are few exampl...
Because of their ubiquitous nature in many cellular processes, modulating protein-protein interactio...
<p>(A) To examine the effect of the particular target residues used in generating the ensemble of po...
Small molecules that bind at protein-protein interfaces may either block or stabilize protein-protei...
Small molecules that bind at protein-protein interfaces may either block or stabilize protein-protei...
<div><p>Small molecules that bind at protein-protein interfaces may either block or stabilize protei...
Although Bcl-xL and Mcl-1, two antideath Bcl-2 members, have similar, flexible binding sites, they c...
<p>Distributions of RMSD over interface atoms (iRMSD) to the closest inhibitor-bound crystal structu...
Small-molecule drug design aims to identify inhibitors that can specifically bind to a functionally ...
Small-molecule drug design aims to identify inhibitors that can specifically bind to a functionally ...
<div><p>Small-molecules that inhibit interactions between specific pairs of proteins have long repre...
Small-molecules that inhibit interactions between specific pairs of proteins have long represented a...
Small-molecules that inhibit interactions between specific pairs of proteins have long represented a...
Despite intense interest and considerable effort via high-throughput screening, there are few exampl...
Despite intense interest and considerable effort via high-throughput screening, there are few exampl...
Despite intense interest and considerable effort via high-throughput screening, there are few exampl...
Because of their ubiquitous nature in many cellular processes, modulating protein-protein interactio...
<p>(A) To examine the effect of the particular target residues used in generating the ensemble of po...
Small molecules that bind at protein-protein interfaces may either block or stabilize protein-protei...
Small molecules that bind at protein-protein interfaces may either block or stabilize protein-protei...
<div><p>Small molecules that bind at protein-protein interfaces may either block or stabilize protei...
Although Bcl-xL and Mcl-1, two antideath Bcl-2 members, have similar, flexible binding sites, they c...
<p>Distributions of RMSD over interface atoms (iRMSD) to the closest inhibitor-bound crystal structu...
Small-molecule drug design aims to identify inhibitors that can specifically bind to a functionally ...
Small-molecule drug design aims to identify inhibitors that can specifically bind to a functionally ...